These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 13630321)
21. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Chan SH; Tan PT; Han HH; Bock HL Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239 [TBL] [Abstract][Full Text] [Related]
22. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine. Black S; Greenberg DP Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875 [TBL] [Abstract][Full Text] [Related]
23. Letter: Immunization: a survey in general practice. Moorhead R Med J Aust; 1974 Apr; 1(17):681. PubMed ID: 4834324 [No Abstract] [Full Text] [Related]
24. [Work of the sonsultation rooms concerning the immunological prevention of pediatric infections]. Braginskaia VN; Sokolova AF; Aleksina SG; Podshivalova VA Pediatriia; 1975 Jan; (1):16-9. PubMed ID: 1129001 [No Abstract] [Full Text] [Related]
25. [Various features of the management of vaccinating children with allergic reactivity]. Sokolova TS; Zakharova NV Pediatriia; 1972 Oct; 51(10):16-20. PubMed ID: 4664875 [No Abstract] [Full Text] [Related]
26. Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future. Halperin SA J Pediatr; 2006 Nov; 149(5):589-91. PubMed ID: 17095321 [No Abstract] [Full Text] [Related]
27. [Prevention in the elderly: vaccination]. Lukas A MMW Fortschr Med; 2008 Nov; 150(45):31-3. PubMed ID: 19058389 [No Abstract] [Full Text] [Related]
35. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Pichichero ME; DeTora LM; Johnson DR Expert Rev Vaccines; 2006 Apr; 5(2):175-87. PubMed ID: 16608418 [TBL] [Abstract][Full Text] [Related]
36. [Evolution of the vaccination timetable in Morocco]. Bouazzaoui NL Bull Acad Natl Med; 2006; 190(4-5):1017-32; discussion 1032-3. PubMed ID: 17195625 [TBL] [Abstract][Full Text] [Related]
37. [Assessment of protective vaccination in children with low and very low birth weight]. Laskowska B Przegl Epidemiol; 1996; 50(4):431-3. PubMed ID: 9132802 [No Abstract] [Full Text] [Related]
38. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
39. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules. Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838 [TBL] [Abstract][Full Text] [Related]
40. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program]. Abarca V K; Cerda L J; Ferreccio R C Rev Med Chil; 2009 Jan; 137(1):10-7. PubMed ID: 19399316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]